EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Machine Learning Model for Atherosclerosis Evaluation and Cardiovascular Risk Prediction Based on Coronary CT Angiography-Analysis From the CREATION Registry

Ying Song, Na Xu, Jianan Zheng, Sida Jia, Cheng Cui, Yin Zhang, Lijian Gao, Zhan Gao, Jue Chen, Lei Song, Jinqing Yuan, Bin Lu, Zhi-hui Hou

Circulation: Cardiovascular Imaging · 2025-12 · 18 (12)

DOI: 10.1161/circimaging.125.018443 ↗
AbstractBibliografische Angaben

Abstract

BACKGROUND: Current atherosclerotic cardiovascular disease risk prediction tools based on traditional risk factors and the coronary artery calcium score have limitations. METHODS: The CREATION study includes patients with suspected coronary artery disease who underwent coronary computed tomography angiography (CCTA) at Fuwai Hospital between 2016 and 2019. The primary outcome was major adverse cardiac events defined as a composite end point of all-cause death, acute myocardial infarction, coronary revascularization, or stroke. Six machine learning survival models were used to create an atherosclerotic cardiovascular disease prediction model. RESULTS: Overall, 8431 participants with analyzable CCTA data were included with a median follow-up of 3.68 years, and 319 major adverse cardiac events (3.8%) occurred (mean age: 54.73±10.21 years, 48.2% were male, 50.9% with symptomatic chest pain). Among 6 machine learning models trained with 48 CCTA parameters, XGBoost showed the best performance and was selected for model development. In the training cohort (n=5901, 70%), the XGBoost model significantly outperformed the clinical risk factors and coronary artery calcium score model (area under the curve, 0.903 versus 0.830; P

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →